Guardian Pharmacy Services (NYSE:GRDN) Stock Rating Upgraded by Wall Street Zen

Guardian Pharmacy Services (NYSE:GRDN) was upgraded by research analysts at Wall Street Zen from a “hold” rating to a “buy” rating in a research report issued to clients and investors on Sunday.

A number of other equities research analysts have also issued reports on GRDN. Truist Financial upped their target price on shares of Guardian Pharmacy Services from $43.00 to $47.00 and gave the stock a “buy” rating in a report on Wednesday, June 17th. Bank of America upped their price objective on shares of Guardian Pharmacy Services from $42.00 to $47.00 and gave the company a “buy” rating in a research note on Wednesday, June 17th. Zacks Research lowered shares of Guardian Pharmacy Services from a “strong-buy” rating to a “hold” rating in a research note on Monday, May 11th. Oppenheimer upped their price target on Guardian Pharmacy Services from $43.00 to $49.00 and gave the company an “outperform” rating in a research report on Friday. Finally, Weiss Ratings upgraded Guardian Pharmacy Services from a “hold (c)” rating to a “hold (c+)” rating in a research report on Thursday. Seven analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $43.83.

Guardian Pharmacy Services Stock Down 6.3%

Shares of NYSE GRDN opened at $41.06 on Friday. The firm has a market cap of $2.04 billion, a price-to-earnings ratio of 39.86, a price-to-earnings-growth ratio of 2.87 and a beta of 0.11. The company’s 50-day simple moving average is $40.96 and its 200-day simple moving average is $37.25. Guardian Pharmacy Services has a 52-week low of $19.30 and a 52-week high of $47.02.

Guardian Pharmacy Services (NYSE:GRDN) last issued its quarterly earnings results on Thursday, August 6th. The company reported $0.29 earnings per share for the quarter, beating analysts’ consensus estimates of $0.26 by $0.03. Guardian Pharmacy Services had a net margin of 4.50% and a return on equity of 29.97%. The firm had revenue of $351.77 million for the quarter, compared to analyst estimates of $340.45 million. Equities research analysts anticipate that Guardian Pharmacy Services will post 1.18 EPS for the current fiscal year.

Institutional Trading of Guardian Pharmacy Services

Several hedge funds have recently made changes to their positions in GRDN. Boston Partners boosted its stake in Guardian Pharmacy Services by 418.7% during the third quarter. Boston Partners now owns 1,046,877 shares of the company’s stock worth $26,922,000 after buying an additional 845,048 shares during the period. Jennison Associates LLC raised its stake in shares of Guardian Pharmacy Services by 609.5% in the 1st quarter. Jennison Associates LLC now owns 822,784 shares of the company’s stock valued at $30,986,000 after acquiring an additional 706,823 shares during the period. Loomis Sayles & Co. L P purchased a new stake in shares of Guardian Pharmacy Services in the 4th quarter valued at approximately $19,126,000. Millennium Management LLC lifted its holdings in shares of Guardian Pharmacy Services by 725.2% in the 3rd quarter. Millennium Management LLC now owns 342,038 shares of the company’s stock worth $8,972,000 after acquiring an additional 300,587 shares during the last quarter. Finally, TimesSquare Capital Management LLC lifted its holdings in shares of Guardian Pharmacy Services by 21.9% in the 4th quarter. TimesSquare Capital Management LLC now owns 1,048,136 shares of the company’s stock worth $31,538,000 after acquiring an additional 187,963 shares during the last quarter.

Guardian Pharmacy Services Company Profile

Guardian Pharmacy Services, Inc, a pharmacy service company, provides a suite of technology-enabled services designed to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities and behavioral health facilities and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; and GuardianShield Programs for LTCFs.